Expert overview of hot news in lymphoma from ASH 2012 (2/2)
Expert overview of hot news in lymphoma from ASH 2012 (2/2)
Multiple myeloma advances for the future suggested by phase I clinical research
Pre-Implantation genetic diagnosis
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study
Investigation of Ki67 biomarker
Results of a randomised phase 2 study of PD 0332991
MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML)
Influence of low penetrant factors on overall cancer risk
Links between EGFR/HER1 signalling and trastuzumab efficacy
Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients
MLN9708 in combination with lenalidomide and dexamethasone